No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs17027947 |
chr4:152778691-152778692 |
Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs187990093 |
chr4:152778694-152778695 |
Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs536760646 |
chr4:152778697-152778698 |
Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs530560251 |
chr4:152778698-152778699 |
Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs555424230 |
chr4:152778720-152778721 |
Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs244404 |
chr4:152778727-152778728 |
Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
7 |
rs534808380 |
chr4:152778758-152778759 |
Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs553341017 |
chr4:152778767-152778768 |
Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs139542732 |
chr4:152778772-152778773 |
Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs545239880 |
chr4:152778795-152778796 |
Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs149717469 |
chr4:152778814-152778815 |
Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs146736987 |
chr4:152778815-152778816 |
Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs370566141 |
chr4:152778821-152778822 |
Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs542783666 |
chr4:152778842-152778843 |
Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs17027948 |
chr4:152778845-152778846 |
Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
16 |
rs140383752 |
chr4:152778866-152778867 |
Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs528701155 |
chr4:152778877-152778878 |
Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs10021481 |
chr4:152778891-152778892 |
Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
19 |
rs372113455 |
chr4:152778921-152778922 |
Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs541235730 |
chr4:152778948-152778949 |
Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs553249641 |
chr4:152778972-152778973 |
Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs368237566 |
chr4:152778992-152778993 |
Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|